HERNDON, VA, November 7, 2013 ─ Exostar, whose cloud-based solutions enable secure, cost-effective business-to-business collaboration, today announced its Life Sciences Identity Hub won accolades from the Northern Virginia Technology Council(NVTC). Exostar was a finalist in the “cloud” category for NVTC’s 2013 Innovator Awards, which were presented at TechCelebration, NVTC’s annual banquet and awards ceremony held on October 30th in Tysons Corner, VA.
Exostar’s Life Sciences Identity Hub is a cloud-based, connect-once solution that allows communities of customers, partners, research organizations, universities, and suppliers to collaborate with one another securely. It is dramatically changing the way life sciences companies manage identities and control access to systems, applications, and information. The Hub is playing a key role in ensuring that the life sciences industry’s evolving collaborative business model continues to gain traction. Global market leaders such as Merck and AstraZeneca are using the Hub today, bringing more users and applications into the community every day.
The NVTC Innovator Awards honor groundbreaking companies and technologies in the region’s technology community. The awards recognize industry pioneers with unique or influential products or services that have had a significant impact with customers in the marketplace. An independent panel evaluated nominations based on criteria including:
- Solution quality;
- Benefits to customers;
- Effects on industry and consumers;
- Demonstrable innovation/transformation; and
- Customer testimonials.
“Being named a finalist for an NVTC Innovator Award, alongside companies including SAP, Northrop Grumman, and SAIC, affirms our vision for the Life Sciences Identity Hub,” said Dan Pfeifle, Exostar’s Vice President of Sales and Marketing. “Hundreds of life sciences organizations and tens of thousands of individuals rely on the Hub to collaborate in a trusted, highly-secure environment. By offering seamless, single sign-on access to applications and data across the community, we are helping life sciences companies expedite the research and development process for the new drugs that will enrich and save lives.”